Treace Medical Concepts, Inc. Cash
Treace Medical Concepts, Inc. (TMCI) had Cash of $5.36 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2025-02-27
- 2024-12-31: Cash $5.36M.
- 2024-03-31: Cash $4.77M.
- 2023-12-31: Cash $9.82M.
- 2023-09-30: Cash $4.54M.
| Period end | Cash |
|---|---|
| 2024-12-31 | $5.36M 10-K · filed 2025-02-27 |
| 2024-03-31 | $4.77M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $9.82M 10-K · filed 2025-02-27 |
| 2023-09-30 | $4.54M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.95M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $3.47M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.26M 10-K · filed 2024-02-27 |
| 2022-09-30 | $2.71M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.52M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $683.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $613.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $203.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $196.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $871.00K 10-Q · filed 2021-05-25 |
| 2020-12-31 | $502.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |